May 12, 2025

Delayed Puberty: Diabetes Risk Signal?

"Our results are surprising as delayed puberty is generally considered a benign condition."

Conexiant

April 30, 2025

AACR 2025: AI-Driven Analysis of Digital Pathology Images May Improve Sarcoma Subtyping Among Pediatric Patients

Researchers explored the potential of a novel artificial intelligence (AI)-based model to classify sarcomas among pediatric patients using digital pathology images alone, according to findings present...

The ASCO Post

April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

October 03, 2023

Ford Dental Institute Announces New 2024 Conference and Speaker Lineup

Ford Dental Institute Announces Conference

AEGIS Dental Network

February 06, 2025

Pediatric Stroke Survivors Show Higher Mental Health Risks

New research reveals children who survive strokes face increased rates of anxiety, depression, and physical symptoms, with age 9 identified as a critical period for mental health challenges, according to findings presented at the 2025 International Stroke Conference.

Conexiant

May 28, 2024

HPV Vaccine Reduces Risk of Multiple Cancers, New Study

New research reveals the HPV vaccine significantly reduces the risk of multiple HPV-related cancers, particularly head and neck cancers in men, highlighting its crucial role in cancer prevention.

Conexiant

March 10, 2025

Baricitinib Effective for Teen Alopecia

Eli Lilly's JAK inhibitor demonstrated 80% scalp hair regrowth in 42.4% of adolescents with severe alopecia areata after just 36 weeks of treatment, outperforming placebo in the Phase 3 BRAVE-AA-PEDS trial.

Conexiant

December 11, 2024

Triple-Drug Combos Show High Response Rates

Cutting-edge triple-drug therapies for leukemia discussed at the American Society of Hematology meeting show promising results in achieving remission and managing residual disease.

Reuters

June 24, 2024

Survodutide Shows Significant HbA1c Reduction

New clinical trials presented at the American Diabetes Association's Scientific Sessions show that survodutide has promising results for reducing HbA1c levels and improving insulin sensitivity, with additional favorable changes in glucose-related biomarkers.

Conexiant